Wells Fargo & Company Bristol Myers Squibb CO Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Wells Fargo & Company holds 6,346,732 shares of BMY stock, worth $357 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

6,346,732

Previous 6,554,289 3.17%

Holding current value

$357 Million

Previous $272 Million 20.66%

% of portfolio

0.08%

Previous 0.07%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$39.66 - $51.75 $8.23 Million - $10.7 Million	-207,557 Reduced 3.17%	6,346,732 $328 Million
Q2 2024 Aug 13, 2024	SELL	$40.25 - $52.99 $115 Million - $151 Million	-2,858,186 Reduced 30.37%	6,554,289 $272 Million
Q1 2024 May 10, 2024	BUY	$47.98 - $54.4 $81.5 Million - $92.4 Million	1,697,862 Added 22.01%	9,412,475 $510 Million
Q4 2023 Feb 09, 2024	SELL	$48.48 - $57.85 $33.7 Million - $40.2 Million	-694,611 Reduced 8.26%	7,714,613 $396 Million
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $54.3 Million - $60.8 Million	-938,809 Reduced 10.04%	8,409,224 $488 Million
Q2 2023 Aug 15, 2023	BUY	$63.71 - $70.74 $173 Million - $192 Million	2,716,162 Added 40.96%	9,348,033 $598 Million
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $21.7 Million - $24.6 Million	329,911 Added 5.24%	6,631,871 $460 Million
Q4 2022 Feb 13, 2023	SELL	$68.48 - $81.09 $15.6 Million - $18.5 Million	-227,968 Reduced 3.49%	6,301,960 $453 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $39,778 - $23.5 Million	-305,989 Reduced 4.48%	6,529,928 $464 Million
Q2 2022 Aug 12, 2022	SELL	$72.62 - $79.98 $84.6 Million - $93.2 Million	-1,165,197 Reduced 14.56%	6,835,917 $526 Million
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $11 Million - $13.2 Million	178,932 Added 2.29%	8,001,114 $584 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $116 Million - $135 Million	-2,162,868 Reduced 21.66%	7,822,182 $488 Million
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $36.8 Million - $43.1 Million	-622,003 Reduced 5.86%	9,985,050 $591 Million
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $34.8 Million - $37.9 Million	-561,819 Reduced 5.03%	10,607,053 $709 Million
Q1 2021 May 13, 2021	SELL	$59.34 - $66.74 $64.2 Million - $72.2 Million	-1,081,686 Reduced 8.83%	11,168,872 $705 Million
Q4 2020 Feb 09, 2021	BUY	$57.74 - $65.43 $48.1 Million - $54.6 Million	833,884 Added 7.3%	12,250,558 $760 Million
Q3 2020 Nov 05, 2020	SELL	$57.43 - $63.64 $24.6 Million - $27.2 Million	-427,658 Reduced 3.61%	11,416,674 $688 Million
Q2 2020 Aug 13, 2020	BUY	$54.82 - $64.09 $56.6 Million - $66.2 Million	1,032,395 Added 9.55%	11,844,332 $696 Million
Q1 2020 May 14, 2020	BUY	$46.4 - $67.43 $502 Million - $729 Million	10,811,937 New	10,811,937 $603 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Bristol Myers Squibb CO Transaction History